Industry: Pharmaceuticals, Biotechnology
Phyton Biotech owns and operates the world’s largest cGMP plant cell fermentation facility with bioreactors up to 75,000 liter in size. Phyton produces paclitaxel for Bristol-Myers Squibb’s TAXOL® oncology product and is now focusing its research and development efforts on developing transgenic protein therapeutics utilizing Phyton’s broad expertise in plant cell suspension culture technology. Phyton Biotech, Inc., based in East Windsor, N.J., is a subsidiary of DFB Pharmaceuticals Inc. Phyton’s proprietary plant cell culture technology platform is used to develop and manufacture products with applications in the pharmaceutical and biotech ( www.phytonbiotech.com )
Phyton Biotech , Inc.
3909 Hulen St.
Fort Worth, Texas 76107
USA
Tel: (609) 426-2520